BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28289065)

  • 1. Gleason grade grouping of prostate cancer is of prognostic value in Asian men.
    Yeong J; Sultana R; Teo J; Huang HH; Yuen J; Tan PH; Khor LY
    J Clin Pathol; 2017 Sep; 70(9):745-753. PubMed ID: 28289065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy.
    Miyake H; Muramaki M; Furukawa J; Tanaka H; Inoue TA; Fujisawa M
    Urol Oncol; 2013 Nov; 31(8):1511-6. PubMed ID: 22658882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
    Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
    Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Gleason score 3 + 4 = 7 prostate cancer with minimal amounts (<6%) vs ≥6% of Gleason pattern 4 tissue in needle biopsy specimens.
    Kır G; Seneldir H; Gumus E
    Ann Diagn Pathol; 2016 Feb; 20():48-51. PubMed ID: 26750655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of >/=8.
    Manoharan M; Bird VG; Kim SS; Civantos F; Soloway MS
    BJU Int; 2003 Oct; 92(6):539-44. PubMed ID: 14511029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.
    Sauter G; Steurer S; Clauditz TS; Krech T; Wittmer C; Lutz F; Lennartz M; Janssen T; Hakimi N; Simon R; von Petersdorff-Campen M; Jacobsen F; von Loga K; Wilczak W; Minner S; Tsourlakis MC; Chirico V; Haese A; Heinzer H; Beyer B; Graefen M; Michl U; Salomon G; Steuber T; Budäus LH; Hekeler E; Malsy-Mink J; Kutzera S; Fraune C; Göbel C; Huland H; Schlomm T
    Eur Urol; 2016 Apr; 69(4):592-598. PubMed ID: 26542947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of risk factors for Gleason score upgrading after radical prostatectomy in a Chinese cohort.
    Zhang B; Wu S; Zhang Y; Guo M; Liu R
    Cancer Med; 2021 Nov; 10(21):7772-7780. PubMed ID: 34528767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.
    Fossati N; Karnes RJ; Cozzarini C; Fiorino C; Gandaglia G; Joniau S; Boorjian SA; Goldner G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T; Briganti A
    Eur Urol; 2016 Apr; 69(4):728-733. PubMed ID: 26497924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
    Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Disease Features in Gleason Score 3 + 4 "Favorable Intermediate-Risk" Prostate Cancer: Implications for Active Surveillance.
    Morlacco A; Cheville JC; Rangel LJ; Gearman DJ; Karnes RJ
    Eur Urol; 2017 Sep; 72(3):442-447. PubMed ID: 27574819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grade Groups Provide Improved Predictions of Pathological and Early Oncologic Outcomes Compared with Gleason Score Risk Groups.
    Kirmiz S; Qi J; Babitz SK; Linsell S; Denton B; Singh K; Auffenberg G; Montie JE; Lane BR
    J Urol; 2019 Feb; 201(2):278-283. PubMed ID: 30195846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic impact of downgrading and upgrading from biopsy to radical prostatectomy among men with Gleason score 7 prostate cancer.
    Jang WS; Koh DH; Kim J; Lee JS; Chung DY; Ham WS; Rha KH; Choi YD
    Prostate; 2019 Dec; 79(16):1805-1810. PubMed ID: 31483062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health system.
    Schulman AA; Howard LE; Tay KJ; Tsivian E; Sze C; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ; Polascik TJ
    Cancer; 2017 Nov; 123(21):4122-4129. PubMed ID: 28662291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the risk of harboring high-grade disease for patients diagnosed with prostate cancer scored as Gleason ≤ 6 on biopsy cores.
    Seisen T; Roudot-Thoraval F; Bosset PO; Beaugerie A; Allory Y; Vordos D; Abbou CC; De La Taille A; Salomon L
    World J Urol; 2015 Jun; 33(6):787-92. PubMed ID: 24985552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External validation of the cancer of the prostate risk assessment score to predict biochemical relapse after radical prostatectomy for prostate cancer in Japanese patients.
    Yoshida T; Nakayama M; Takeda K; Arai Y; Kakimoto K; Nishimura K
    Urol Int; 2012; 89(1):45-51. PubMed ID: 22441013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.
    Özsoy M; D'Andrea D; Moschini M; Foerster B; Abufaraj M; Mathieu R; Briganti A; Karakiewicz PI; Roupret M; Seitz C; Czech AK; Susani M; Shariat SF
    Urol Oncol; 2018 Apr; 36(4):158.e1-158.e6. PubMed ID: 29288003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Gleason pattern in biopsy Gleason score 7 is predictive of adverse histopathological features and biochemical failure following radical prostatectomy.
    Berg KD; Røder MA; Brasso K; Vainer B; Iversen P
    Scand J Urol; 2014 Apr; 48(2):168-76. PubMed ID: 23889119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.
    Epstein JI; Zelefsky MJ; Sjoberg DD; Nelson JB; Egevad L; Magi-Galluzzi C; Vickers AJ; Parwani AV; Reuter VE; Fine SW; Eastham JA; Wiklund P; Han M; Reddy CA; Ciezki JP; Nyberg T; Klein EA
    Eur Urol; 2016 Mar; 69(3):428-35. PubMed ID: 26166626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.